Cognition Therapeutics Stock Forecast - Simple Exponential Smoothing

CGTX Stock  USD 1.46  0.08  5.80%   
The Simple Exponential Smoothing forecasted value of Cognition Therapeutics on the next trading day is expected to be 1.45 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.63. Cognition Stock Forecast is based on your current time horizon.
At this time, the RSI of Cognition Therapeutics' share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cognition Therapeutics, making its price go up or down.

Momentum 45

 Impartial

 
Oversold
 
Overbought
The successful prediction of Cognition Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cognition Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cognition Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.08)
EPS Estimate Current Year
(0.39)
EPS Estimate Next Year
(0.34)
Wall Street Target Price
3.5
EPS Estimate Current Quarter
(0.09)
Using Cognition Therapeutics hype-based prediction, you can estimate the value of Cognition Therapeutics from the perspective of Cognition Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.

Cognition Therapeutics Hype to Price Pattern

Investor biases related to Cognition Therapeutics' public news can be used to forecast risks associated with an investment in Cognition. The trend in average sentiment can be used to explain how an investor holding Cognition can time the market purely based on public headlines and social activities around Cognition Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cognition Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cognition Therapeutics.
The Simple Exponential Smoothing forecasted value of Cognition Therapeutics on the next trading day is expected to be 1.45 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.63.

Cognition Therapeutics after-hype prediction price

    
  USD 1.46  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cognition Therapeutics to cross-verify your projections.
For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.Inventory Turnover is likely to drop to 0.55 in 2026. Payables Turnover is likely to drop to 0.04 in 2026. Common Stock Shares Outstanding is likely to drop to about 30.2 M in 2026. Net Loss is likely to drop to about (20.2 M) in 2026.

Cognition Therapeutics Additional Predictive Modules

Most predictive techniques to examine Cognition price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cognition using various technical indicators. When you analyze Cognition charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cognition Therapeutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Cognition Therapeutics are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Cognition Therapeutics prices get older.

Cognition Therapeutics Simple Exponential Smoothing Price Forecast For the 19th of January

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Cognition Therapeutics on the next trading day is expected to be 1.45 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.63.
Please note that although there have been many attempts to predict Cognition Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cognition Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cognition Therapeutics Stock Forecast Pattern

Backtest Cognition TherapeuticsCognition Therapeutics Price PredictionBuy or Sell Advice 

Cognition Therapeutics Forecasted Value

In the context of forecasting Cognition Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cognition Therapeutics' downside and upside margins for the forecasting period are 0.01 and 6.55, respectively. We have considered Cognition Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.46
1.45
Expected Value
6.55
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cognition Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Cognition Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.188
BiasArithmetic mean of the errors 0.0057
MADMean absolute deviation0.0605
MAPEMean absolute percentage error0.0389
SAESum of the absolute errors3.6325
This simple exponential smoothing model begins by setting Cognition Therapeutics forecast for the second period equal to the observation of the first period. In other words, recent Cognition Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Cognition Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cognition Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cognition Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.466.56
Details
Intrinsic
Valuation
LowRealHigh
0.061.276.37
Details
4 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details

Other Forecasting Options for Cognition Therapeutics

For every potential investor in Cognition, whether a beginner or expert, Cognition Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cognition Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cognition. Basic forecasting techniques help filter out the noise by identifying Cognition Therapeutics' price trends.

Cognition Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cognition Therapeutics stock to make a market-neutral strategy. Peer analysis of Cognition Therapeutics could also be used in its relative valuation, which is a method of valuing Cognition Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cognition Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cognition Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cognition Therapeutics' current price.

Cognition Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Cognition Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cognition Therapeutics shares will generate the highest return on investment. By undertsting and applying Cognition Therapeutics stock market strength indicators, traders can identify Cognition Therapeutics entry and exit signals to maximize returns.

Cognition Therapeutics Risk Indicators

The analysis of Cognition Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cognition Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cognition stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.